Mandy Lauw (@mandynlauw) 's Twitter Profile
Mandy Lauw

@mandynlauw

MD PhD,Hematologist @ErasmusMC @clotterdam🇳🇱 Bridging malignant/non-malignant #hematology. Thrombosis in (Heme) Malignancies. Past-Chair of @Young_EHA

ID: 838775767039365120

calendar_today06-03-2017 15:38:21

2,2K Tweet

1,1K Followers

660 Following

Mandy Lauw (@mandynlauw) 's Twitter Profile Photo

Very proud of my PhD student Amica Ko for presenting her first #oral at #ISTH2024! 😊👏🏼 Important topic of #CART associated #thrombosis and #bleeding. Preliminary results show incidence rates are substantial justifying expansion of cohort and evaluation of preventive measures

Fionnuala Ní Áinle (@fniainle) 's Twitter Profile Photo

Wow- Very nice Dutch study evaluating a community-initiated DVT care pathway avoiding ED #ISTH2024 👏👏 N=460 No major bleeding Minor bleeding 17.8% No deaths Single centre study NVTEP Thrombosis Ireland National Patient Safety Office

Wow- Very nice Dutch study evaluating a community-initiated DVT care pathway avoiding ED #ISTH2024 👏👏
N=460
No major bleeding
Minor bleeding 17.8%
No deaths 
Single centre study 
<a href="/NVTEProgramme/">NVTEP</a> <a href="/ThrombosisIrL/">Thrombosis Ireland</a> <a href="/npsoIRL/">National Patient Safety Office</a>
Marc Carrier (@marccarrier1) 's Twitter Profile Photo

Dr. Nicola Potere reported that older age, low BMI, thrombocytopenia and renal impairment are associated with decision to use low dose DOAC for secondary prevention in patient with VTE. No difference in recurrent VTE or major bleeding between the two groups at #ISTH2024

Dr. <a href="/NicolaPotereMD/">Nicola Potere</a> reported that older age, low BMI, thrombocytopenia and renal impairment are associated with decision to use low dose DOAC for secondary prevention in patient with VTE. No difference in recurrent VTE or major bleeding between the two groups at #ISTH2024
Marc Carrier (@marccarrier1) 's Twitter Profile Photo

Do you find tumor thrombus challenging ? Dr. Tzu-Fei Wang reporting that these patients are at high risk of recurrent thrombosis, bleeding and mortality independent of anticoagulation status (none, therapeutic or prophylactic). Future trials are needed!! #ISTH2024

Do you find tumor thrombus challenging ?

Dr. <a href="/TzufeiWang/">Tzu-Fei Wang</a> reporting that these patients are at high risk of recurrent thrombosis, bleeding and mortality independent of anticoagulation status (none, therapeutic or prophylactic). Future trials are needed!!
#ISTH2024
Marc Carrier (@marccarrier1) 's Twitter Profile Photo

Dr. Geoff Barnes presented an elegant SOA on the new FXI inhibitors at #ISTH2024 From types of new agent to potential indication and a comprehensive summary of Phase 2 trials. Looking forward to the publications of the phase 3 trials!

Dr. <a href="/GBarnesMD/">Geoff Barnes</a> presented an elegant SOA on the new FXI inhibitors at #ISTH2024 From types of new agent to potential indication and a comprehensive summary of Phase 2 trials. Looking forward to the publications of the phase 3 trials!
Mandy Lauw (@mandynlauw) 's Twitter Profile Photo

Can only agree!! Thanks so much Thita Joy Chiasakul for all your tips for #Bangkok, restaurant reservations and hospitality. And above all, being such a nice and talented #earlycareer colleague! #ISTH2024 #ISTHECC #thrombosis

Can only agree!! Thanks so much <a href="/joythitac/">Thita Joy Chiasakul</a> for all your tips for #Bangkok, restaurant reservations and hospitality. And above all, being such a nice and talented #earlycareer colleague! #ISTH2024 #ISTHECC #thrombosis
Saskia Middeldorp (@middeldorps) 's Twitter Profile Photo

Thanks European Hematology Association for given me the opportunity to tell what inspires me in my #thrombosis research and career 🩺🩸#EHA2024 emjreviews.com/hematology/con…

Mattias Mandorfer (@mattiasmandorf1) 's Twitter Profile Photo

It's out: The standard reference on 🩸portal vein thrombosis🩸 👉 diagnosis 👉 management 👉 endpoints for future clinical studies Chapeau Rautou Pierre-Emmanuel & team 🔗 authors.elsevier.com/c/1jO-d8nByrCi… #LiverTwitter The Lancet Gastroenterology & Hepatology

It's out: The standard reference on
🩸portal vein thrombosis🩸
👉 diagnosis
👉 management
👉 endpoints for future clinical studies
Chapeau <a href="/RautouE/">Rautou Pierre-Emmanuel</a> &amp; team
🔗 authors.elsevier.com/c/1jO-d8nByrCi…
#LiverTwitter <a href="/LancetGastroHep/">The Lancet Gastroenterology & Hepatology</a>
CancerNetwork® (@cancernetwrk) 's Twitter Profile Photo

After the first 60 days of treatment, thrombosis occurred in 17% of patients who received low-molecular weight heparin compared with 11% of patients who did not receive thromboprophylaxis (adjusted HR, 1.52; 95% CI, 0.79-2.90). #leusm | Mandy Lauw cancernetwork.com/view/low-molec…

Raul Cordoba, MD, PhD #WCLLD24 (@drraulcordoba) 's Twitter Profile Photo

🚨🚨🚨 DO NOT MISS THIS OPPORTUNITY!! Apply for European Hematology Association CRTH 2025. Deadline has been extended until September 24, 2024. There are still spots available!! #hematology #research #clinicalresearch #clinicaltrials

🚨🚨🚨 DO NOT MISS THIS OPPORTUNITY!! 

Apply for <a href="/EHA_Hematology/">European Hematology Association</a> CRTH 2025. 

Deadline has been extended until September 24, 2024. 

There are still spots available!! 

#hematology #research #clinicalresearch #clinicaltrials
Raul Cordoba, MD, PhD #WCLLD24 (@drraulcordoba) 's Twitter Profile Photo

#CRTH2024 has come to its end. Amazing scholars, high expertise faculty, extraordinary organization. Thanks to European Hematology Association for this outstanding #mentoring experience. Proud to be part of it. Looking forward to next year edition. Please, apply!! ehaweb.org/research/resea…

#CRTH2024 has come to its end. Amazing scholars, high expertise faculty, extraordinary organization. Thanks to <a href="/EHA_Hematology/">European Hematology Association</a> for this outstanding #mentoring experience. Proud to be part of it. Looking forward to next year edition. Please, apply!! ehaweb.org/research/resea…
YoungEHA (@young_eha) 's Twitter Profile Photo

#Burnout is a major issue among healthcare professionals and #hematology is no different but hard evidence is lacking. Complete our survey to better understand this 👉 research.net/r/?sm=XpL1E_2F…

#Burnout is a major issue among healthcare professionals and #hematology is no different but hard evidence is lacking. Complete our survey to better understand this 👉 research.net/r/?sm=XpL1E_2F…
Behnood Bikdeli (@bbikdeli) 's Twitter Profile Photo

🚨Interactions between #food 🥘🍲/🌿& oral #anticoagulants: There's plenty for #warfarin, but few important ones for #DOACs, too! Azita Talasaz Seminars in Thrombosis and Hemostasis Brigham and Women’s Research And a lot to study in future #HemeTwitter #CardioTwitter #Thrombosis👇: tinyurl.com/2v373thz

🚨Interactions between #food 🥘🍲/🌿&amp; oral #anticoagulants: There's plenty for #warfarin, but few important ones for #DOACs, too! <a href="/AzitaTalasaz/">Azita Talasaz</a> <a href="/SemThrombHemost/">Seminars in Thrombosis and Hemostasis</a> <a href="/BrighamResearch/">Brigham and Women’s Research</a>  And a lot to study in future #HemeTwitter #CardioTwitter #Thrombosis👇:

tinyurl.com/2v373thz